Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piera Capranzano

Showing results (71-80 of 224) with videos related to

Pageof 23
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 21, 2017
Current status of transcatheter mitral valve therapy in Europe: results from an EAPCI survey (Part II)Anna Sonia Petronio, Piera Capranzano, Emanuele Barbato, et al.
The Canadian Journal of Cardiology|June 30, 2015
One-Year Coverage by Optical Coherence Tomography of a Bioresorbable Scaffold Neocarina: Is It Safe to Discontinue Dual-Antiplatelet Therapy?Piera Capranzano, Bruno Francaviglia, Claudia Ina Tamburino, et al.
JACC. Cardiovascular Interventions|October 1, 2018
Lipid Plaque Modification During Resorption of Absorb Bioresorbable Scaffold: Insights From Optical Coherence TomographyPiera Capranzano, Bruno Francaviglia, Maria D Radu, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 11, 2016
Current status of transcatheter valve therapy in Europe: results from an EAPCI surveyAnna Sonia Petronio, Piera Capranzano, Emanuele Barbato, et al.
The Canadian Journal of Cardiology|June 6, 2017
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric StrutsBruno Francaviglia, Piera Capranzano, Davide Capodanno, et al.
International Journal of Cardiology|June 16, 2024
Use of DOACs in frail elderly patients in light of class genericizationGiovanni Luca Botto, Piera Capranzano, Paolo Colonna, et al.
JACC. Cardiovascular Interventions|April 18, 2016
Is the Metallic Stent a Safe Treatment for Bioresorbable Scaffold Failure?: Insights From Optical Coherence TomographyPiera Capranzano, Bruno Francaviglia, Davide Capodanno, et al.
Journal of the American College of Cardiology|September 12, 2009
Pharmacogenetics in cardiovascular antithrombotic therapyFrancisco Marín, Rocío González-Conejero, Piera Capranzano, et al.
Expert Review of Cardiovascular Therapy|March 19, 2026
Percutaneous coronary intervention in high bleeding risk patients: a review of contemporary management strategiesGiuseppe Andò, Giulia Cavolina, Alessio Villari, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 18, 2008
Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologistsDominick J Angiolillo, Siva Suryadevara, Piera Capranzano, et al.
Pageof 23

Showing results (71-80 of 224) with videos related to

Sort By:
Pageof 23
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 21, 2017
Current status of transcatheter mitral valve therapy in Europe: results from an EAPCI survey (Part II)Anna Sonia Petronio, Piera Capranzano, Emanuele Barbato, et al.
The Canadian Journal of Cardiology|June 30, 2015
One-Year Coverage by Optical Coherence Tomography of a Bioresorbable Scaffold Neocarina: Is It Safe to Discontinue Dual-Antiplatelet Therapy?Piera Capranzano, Bruno Francaviglia, Claudia Ina Tamburino, et al.
JACC. Cardiovascular Interventions|October 1, 2018
Lipid Plaque Modification During Resorption of Absorb Bioresorbable Scaffold: Insights From Optical Coherence TomographyPiera Capranzano, Bruno Francaviglia, Maria D Radu, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 11, 2016
Current status of transcatheter valve therapy in Europe: results from an EAPCI surveyAnna Sonia Petronio, Piera Capranzano, Emanuele Barbato, et al.
The Canadian Journal of Cardiology|June 6, 2017
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric StrutsBruno Francaviglia, Piera Capranzano, Davide Capodanno, et al.
International Journal of Cardiology|June 16, 2024
Use of DOACs in frail elderly patients in light of class genericizationGiovanni Luca Botto, Piera Capranzano, Paolo Colonna, et al.
JACC. Cardiovascular Interventions|April 18, 2016
Is the Metallic Stent a Safe Treatment for Bioresorbable Scaffold Failure?: Insights From Optical Coherence TomographyPiera Capranzano, Bruno Francaviglia, Davide Capodanno, et al.
Journal of the American College of Cardiology|September 12, 2009
Pharmacogenetics in cardiovascular antithrombotic therapyFrancisco Marín, Rocío González-Conejero, Piera Capranzano, et al.
Expert Review of Cardiovascular Therapy|March 19, 2026
Percutaneous coronary intervention in high bleeding risk patients: a review of contemporary management strategiesGiuseppe Andò, Giulia Cavolina, Alessio Villari, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 18, 2008
Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologistsDominick J Angiolillo, Siva Suryadevara, Piera Capranzano, et al.
Pageof 23